Skip to search formSkip to main contentSkip to account menu

BMY 28142

Known as: BMY-28142 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cefepime

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1987
Highly Cited
1987
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine
A high-pressure liquid chromatographic assay was developed for the quantitative analysis of a new cephalosporin, BMY-28142, in… 
1987
1987
Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys
The disposition of the novel cephalosporin cefepime (BMY-28142) was characterized for intravenous administration of single doses… 
Highly Cited
1986
Highly Cited
1986
Synthesis and structure-activity relationships of a new series of cephalosporins, BMY-28142 and related compounds.
The synthesis of a series of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-oxyiminoacetamido] -3-ammoniomethyl-3-cephems is described… 
Highly Cited
1985
Highly Cited
1985
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics
BMY 28142, a new broad-spectrum semisynthetic cephalosporin, was evaluated in vitro and in vivo in comparison with ceftazidime… 
Highly Cited
1985
Highly Cited
1985
In vitro studies of BMY-28142, a new broad-spectrum cephalosporin
BMY-28142 was compared with other broad-spectrum antibiotics against gram-positive cocci and gram-negative bacilli. BMY-28142 was… 
1985
1985
In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin
The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639… 
Highly Cited
1985
Highly Cited
1985
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin
The in vitro activity of BMY-28142, a new cephalosporin, was tested by a broth microdilution system and compared with those of… 
1985
1985
In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents
The in vitro susceptibility of 406 clinical isolates to BMY-28142, a new semisynthetic cephem, was evaluated and compared with… 
1985
1985
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci
We evaluated the activity of BMY-28142 against a K1 E. coli strain and a type III group B streptococcal strain in vitro and in… 
1985
1985
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum
The antibacterial activity of BMY-28142, a new aminothiazole cephalosporin, was measured by standardized broth microdilution and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)